Literature DB >> 2412582

The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation.

G Storm, L van Bloois, M Brouwer, D J Crommelin.   

Abstract

A new method that involves the use of the cation exchange resin Dowex 50W-X4 to remove non-encapsulated drugs from liposome dispersions was investigated. Cytostatic drugs widely varying in their molecular structure can be removed from aqueous solutions by Dowex 50W-X4. The applicability of the resin to separate free from liposome-bound drugs was illustrated for a number of cytostatic drugs (cisplatin, doxorubicin, vincristine). The technique presented allows for a rapid, efficient and convenient procedure for the free drug removal from liposome dispersions without dilution of the liposomal preparation. Studies with liposome-encapsulated drugs will be facilitated by the use of this method, since it avoids many of the problems introduced by conventional methods as dialysis, gel filtration and centrifugation/washing. To elucidate the interaction mechanism of doxorubicin with Dowex 50W-X4, alternative adsorbents were studied for their doxorubicin binding properties. In the adsorption process of doxorubicin onto Dowex 50W-X4 both electrostatic (ion exchange) and hydrophobic effects play a role. The results indicate that hydrophobic contributions to the interaction are responsible for the high resistance offered by the binding forces against desorption of adsorbed doxorubicin. For other adsorbents the interactions are either mainly of an electrostatic or a hydrophobic nature.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412582     DOI: 10.1016/0005-2736(85)90008-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes.

Authors:  S Bandak; A Ramu; Y Barenholz; A Gabizon
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Authors:  D Papahadjopoulos; T M Allen; A Gabizon; E Mayhew; K Matthay; S K Huang; K D Lee; M C Woodle; D D Lasic; C Redemann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Co-Delivery of Ciprofloxacin and Colistin in Liposomal Formulations with Enhanced In Vitro Antimicrobial Activities against Multidrug Resistant Pseudomonas aeruginosa.

Authors:  Shaoning Wang; Shihui Yu; Yuwei Lin; Peizhi Zou; Guihong Chai; Heidi H Yu; Hasini Wickremasinghe; Nivedita Shetty; Junhong Ling; Jian Li; Qi Tony Zhou
Journal:  Pharm Res       Date:  2018-08-09       Impact factor: 4.200

4.  Sterilization of liposomes by heat treatment.

Authors:  N J Zuidam; S S Lee; D J Crommelin
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

5.  Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.

Authors:  P A Steerenberg; G Storm; G de Groot; A Claessen; J J Bergers; M A Franken; Q G van Hoesel; K L Wubs; W H de Jong
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

6.  Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs.

Authors:  A A Gabizon; Y Barenholz; M Bialer
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

Review 7.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

8.  A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat.

Authors:  G Storm; Q G van Hoesel; G de Groot; W Kop; P A Steerenberg; F C Hillen
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

9.  Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes.

Authors:  Alexander V Andriyanov; Erez Koren; Yechezkel Barenholz; S Nahum Goldberg
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

10.  Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.

Authors:  M H Vingerhoeds; P A Steerenberg; J J Hendriks; L C Dekker; Q G Van Hoesel; D J Crommelin; G Storm
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.